array:6 [ "_controller" => "Drupal\devel\Controller\EntityDebugController::entityRender" "_title" => "Devel Render" "wikifolio" => Drupal\wikifolio\Entity\Wikifolio {#1724 #entityTypeId: "wikifolio" #enforceIsNew: null #typedData: null #cacheContexts: [] #cacheTags: [] #cacheMaxAge: -1 #_serviceIds: [] #_entityStorages: [] #values: array:34 [ "id" => array:1 [ "x-default" => "8543" ] "isin" => array:1 [ "x-default" => "DE000LS9RVK4" ] "wkn" => array:1 [ "x-default" => "LS9RVK" ] "name" => array:1 [ "x-default" => "CLIMAX02" ] "short_description" => array:1 [ "x-default" => "Climax Institutes Invest Plus" ] "long_description" => array:1 [ "x-default" => """ Climax Institutes Invest Plus ist stark an mein seit Jahrzehnten angelegtes reales, hochspekulatives, breit diversifiziertes, technologielastiges und chancenorientiertes Portfolio angelehnt. Die Titel sollten dabei typischerweise über viele Jahre gehalten werden. Neben Aktien mit technologisch interessanten, teilweise einzigartigen Ansätzen können auch immer wieder hochspekulative Turnaround-, Penny-Stocks sowie Beteiligungs- und Venture Capital-AGs beigemischt sein.\r\n In der Plus Variante soll durch gezielte Gewichtung (bis auf "0") und Beimischung von Krypto, Gold und Rohstoff-ETFs bzw. ETCs auch in Abhängigkeit von der jeweiligen allgemeinen globalen wirtschaftlichen Situation, zusätzliche Stabilität und Ertrag generiert werden. Die Auswahl der Titel soll in erster Line durch meine persönliche Einschätzung des zukünftigen Potentials und der daraus resultierenden Aussichten erfolgen. Das Chance/Risiko Verhältnis ist eine entscheidende Größe bei meiner Auswahl und das nach meiner subjektiven Einschätzung. Ich suche nach längerfristigen großen Chancen mit entsprechenden großen Risiken, zumindest in den einzelnen Titeln. Meine Einschätzung muss dabei nicht unbedingt dem allgemeinen Konsens entsprechen. \r\n Ich erwarte von "Climax Institutes Invest Plus" mittel- und langfristig eine deutliche Outperformance, bei gleichzeitig deutlich erhöhter Volatilität, gegenüber anderen Portfolios und Indizes ohne entsprechende Beimischung. Aufgrund des Vorgehens nahezu aller Notenbanken und der daraus resultierenden extremen Geldmengenausweitung seit 2000 (New Economy Krise), 2008 (Subprime Krise) und nun 2020 (Corona Krise) befürchte ich Schlimmes.\r\n Unter vielen Experten scheint es diesbezüglich einen Konsens zu geben, nur der Zeithorizont differiert. \r\n Dass zudem immer mehr Akteure zu glauben scheinen "Diesmal ist alles anders", macht die Sache keinesfalls besser.\r\n "Climax Institutes Invest Plus" versucht diese möglichen zukünftigen Verwerfungen möglichst zu kompensieren oder gar in Gewinne zu verwandeln. """ ] "status" => array:1 [ "x-default" => "Investable" ] "trader_name" => array:1 [ "x-default" => "SupaFlash" ] "symbol" => array:1 [ "x-default" => "WFCLIMAX02" ] "creation_date" => array:1 [ "x-default" => "1612187153" ] "issuing_date" => array:1 [ "x-default" => "1624512323" ] "daily_free_relative" => array:1 [ "x-default" => "0.95" ] "performance_free_relative" => array:1 [ "x-default" => "10" ] "cash" => array:1 [ "x-default" => "-140.408" ] "url" => array:1 [ "x-default" => "https://www.wikifolio.com/de/ch/w/wfclimax02" ] "href" => array:1 [ "x-default" => "https://api.wikifolio.com/api/v1/wikifolios/de000ls9rvk4" ] "wikifolio_tags" => array:1 [ "x-default" => "a:10:{i:0;a:3:{s:4:"Name";s:3:"etf";s:16:"ShortDescription";s:4:"ETFs";s:8:"TagGroup";s:15:"Anlageuniversum";}i:1;a:3:{s:4:"Name";s:6:"akteur";s:16:"ShortDescription";s:13:"Aktien Europa";s:8:"TagGroup";s:15:"Anlageuniversum";}i:2;a:3:{s:4:"Name";s:5:"aktde";s:16:"ShortDescription";s:18:"Aktien Deutschland";s:8:"TagGroup";s:15:"Anlageuniversum";}i:3;a:3:{s:4:"Name";s:6:"divers";s:16:"ShortDescription";s:20:"Aktiv diversifiziert";s:8:"TagGroup";s:11:"Handelsstil";}i:4;a:3:{s:4:"Name";s:8:"sonstige";s:16:"ShortDescription";s:16:"Sonstige Analyse";s:8:"TagGroup";s:20:"Entscheidungsfindung";}i:5;a:3:{s:4:"Name";s:6:"aktint";s:16:"ShortDescription";s:20:"Aktien International";s:8:"TagGroup";s:15:"Anlageuniversum";}i:6;a:3:{s:4:"Name";s:6:"akthot";s:16:"ShortDescription";s:17:"Aktien Hot Stocks";s:8:"TagGroup";s:15:"Anlageuniversum";}i:7;a:3:{s:4:"Name";s:8:"langf-st";s:16:"ShortDescription";s:23:"Mittel- bis langfristig";s:8:"TagGroup";s:36:"ExtendedSearchInvestmentHorizonGroup";}i:8;a:3:{s:4:"Name";s:6:"aktusa";s:16:"ShortDescription";s:10:"Aktien USA";s:8:"TagGroup";s:15:"Anlageuniversum";}i:9;a:3:{s:4:"Name";s:10:"regelm-akt";s:16:"ShortDescription";s:24:"Regelmäßige Aktivität";s:8:"TagGroup";s:18:"Qualitätsmerkmale";}}" ] "rankings" => array:1 [ "x-default" => "a:9:{i:0;a:4:{s:4:"Name";s:3:"aum";s:16:"ShortDescription";s:19:"Summe Investitionen";s:5:"Value";d:10217.274257;s:5:"Index";i:2246;}i:1;a:4:{s:4:"Name";s:8:"topwikis";s:16:"ShortDescription";s:23:"Top-wikifolio-Rangliste";s:5:"Value";d:102.86347335067;s:5:"Index";i:2094;}i:2;a:4:{s:4:"Name";s:6:"perf1m";s:16:"ShortDescription";s:19:"Performance 1 Monat";s:5:"Value";d:-9.317233916;s:5:"Index";i:61674;}i:3;a:4:{s:4:"Name";s:7:"perf12m";s:16:"ShortDescription";s:18:"Performance 1 Jahr";s:5:"Value";d:-1.611770223;s:5:"Index";i:50146;}i:4;a:4:{s:4:"Name";s:8:"perfever";s:16:"ShortDescription";s:23:"Performance seit Beginn";s:5:"Value";d:-2.647974371565;s:5:"Index";i:63118;}i:5;a:4:{s:4:"Name";s:6:"perf3m";s:16:"ShortDescription";s:20:"Performance 3 Monate";s:5:"Value";d:-1.196021772;s:5:"Index";i:53047;}i:6;a:4:{s:4:"Name";s:6:"perf6m";s:16:"ShortDescription";s:20:"Performance 6 Monate";s:5:"Value";d:-8.127212561;s:5:"Index";i:55600;}i:7;a:4:{s:4:"Name";s:7:"maxdraw";s:16:"ShortDescription";s:26:"maximaler Verlust (bisher)";s:5:"Value";d:-54.2337678939;s:5:"Index";i:82216;}i:8;a:4:{s:4:"Name";s:11:"sharperatio";s:16:"ShortDescription";s:23:"Sharpe Ratio (365 Tage)";s:5:"Value";d:-0.159964029893;s:5:"Index";i:32621;}}" ] "wikifolio_items" => array:1 [ "x-default" => "a:44:{i:0;a:8:{s:4:"ISIN";s:12:"US85916J4094";s:3:"WKN";s:6:"A1J09L";s:16:"ShortDescription";s:25:"STEREOTAXIS DL-,01";s:13:"AbsoluteValue";d:11565;s:13:"RelativeValue";d:-82.36712982464438;s:12:"AbsoluteGain";d:-5334.9999999975;s:12:"RelativeGain";d:-0.31568047337267985;s:8:"Quantity";d:7500;}i:1;a:8:{s:4:"ISIN";s:12:"US88688T2096";s:3:"WKN";s:6:"A41VMJ";s:16:"ShortDescription";s:23:"TILRAY BRANDS NEW O.N.";s:13:"AbsoluteValue";d:12300;s:13:"RelativeValue";d:-87.6018760780913;s:12:"AbsoluteGain";d:-11487.39999999;s:12:"RelativeGain";d:-0.4829195288259679;s:8:"Quantity";d:3000;}i:2;a:8:{s:4:"ISIN";s:12:"US88554D2053";s:3:"WKN";s:6:"888346";s:16:"ShortDescription";s:25:"3 D SYS CORP. DL-,001";s:13:"AbsoluteValue";d:14760;s:13:"RelativeValue";d:-105.12225129370955;s:12:"AbsoluteGain";d:-3260;s:12:"RelativeGain";d:-0.18091009988901222;s:8:"Quantity";d:5000;}i:3;a:8:{s:4:"ISIN";s:12:"US77543R1023";s:3:"WKN";s:6:"A2DW4X";s:16:"ShortDescription";s:25:"ROKU INC CL. A DL-,0001";s:13:"AbsoluteValue";d:23852;s:13:"RelativeValue";d:-169.87641855403524;s:12:"AbsoluteGain";d:11067.5;s:12:"RelativeGain";d:0.8656967421486957;s:8:"Quantity";d:200;}i:4;a:8:{s:4:"ISIN";s:12:"US7479066000";s:3:"WKN";s:6:"A40M9N";s:16:"ShortDescription";s:18:"QUANTUM CORP. DL0";s:13:"AbsoluteValue";d:32325;s:13:"RelativeValue";d:-230.22200359547165;s:12:"AbsoluteGain";d:19920.5000000025;s:12:"RelativeGain";d:1.6059091458750063;s:8:"Quantity";d:2500;}i:5;a:8:{s:4:"ISIN";s:12:"US69608A1088";s:3:"WKN";s:6:"A2QA4J";s:16:"ShortDescription";s:25:"PALANTIR TECHNOLOGIES INC";s:13:"AbsoluteValue";d:124717.8;s:13:"RelativeValue";d:-888.2531105961118;s:12:"AbsoluteGain";d:95836.18907562974;s:12:"RelativeGain";d:3.318242508237768;s:8:"Quantity";d:1090;}i:6;a:8:{s:4:"ISIN";s:12:"US09075V1026";s:3:"WKN";s:6:"A2PSR2";s:16:"ShortDescription";s:24:"BIONTECH SE SPON. ADRS 1";s:13:"AbsoluteValue";d:49662;s:13:"RelativeValue";d:-353.69791624310324;s:12:"AbsoluteGain";d:-12985.6615384613;s:12:"RelativeGain";d:-0.20728086603023496;s:8:"Quantity";d:620;}i:7;a:8:{s:4:"ISIN";s:12:"US12468P1049";s:3:"WKN";s:6:"A2QJVE";s:16:"ShortDescription";s:25:"C3 AI INC. CL.A DL -,001";s:13:"AbsoluteValue";d:5590;s:13:"RelativeValue";d:-39.81255994118133;s:12:"AbsoluteGain";d:651.55;s:12:"RelativeGain";d:0.1319341088803167;s:8:"Quantity";d:625;}i:8;a:8:{s:4:"ISIN";s:12:"US20602D1019";s:3:"WKN";s:6:"A2QG33";s:16:"ShortDescription";s:25:"CONCENTRIX CORP. DL-,0001";s:13:"AbsoluteValue";d:441.4;s:13:"RelativeValue";d:-3.143696593566626;s:12:"AbsoluteGain";d:-222.6;s:12:"RelativeGain";d:-0.3352409638554217;s:8:"Quantity";d:20;}i:9;a:8:{s:4:"ISIN";s:12:"US3847471014";s:3:"WKN";s:6:"A40F8M";s:16:"ShortDescription";s:17:"GRAIL INC. DL-,01";s:13:"AbsoluteValue";d:25750;s:13:"RelativeValue";d:-183.39417146429682;s:12:"AbsoluteGain";d:15750;s:12:"RelativeGain";d:1.575;s:8:"Quantity";d:500;}i:10;a:8:{s:4:"ISIN";s:12:"US3741631036";s:3:"WKN";s:6:"902213";s:16:"ShortDescription";s:25:"GERON CORP. (DEL.) DL-001";s:13:"AbsoluteValue";d:316.8;s:13:"RelativeValue";d:-2.2562824667918147;s:12:"AbsoluteGain";d:-9.9;s:12:"RelativeGain";d:-0.030303030303030304;s:8:"Quantity";d:300;}i:11;a:8:{s:4:"ISIN";s:12:"KYG970081173";s:3:"WKN";s:6:"A2QJCN";s:16:"ShortDescription";s:24:"WUXI BIOLOGICS-0,0000083";s:13:"AbsoluteValue";d:2628;s:13:"RelativeValue";d:-18.716888644977555;s:12:"AbsoluteGain";d:-323.2199999992;s:12:"RelativeGain";d:-0.10952080834342666;s:8:"Quantity";d:800;}i:12;a:8:{s:4:"ISIN";s:12:"KYG9830T1067";s:3:"WKN";s:6:"A2JNY1";s:16:"ShortDescription";s:17:"XIAOMI CORP. CL.B";s:13:"AbsoluteValue";d:41730;s:13:"RelativeValue";d:-297.20538932835365;s:12:"AbsoluteGain";d:-6090;s:12:"RelativeGain";d:-0.1273525721455458;s:8:"Quantity";d:15000;}i:13;a:8:{s:4:"ISIN";s:12:"NL0015000YE1";s:3:"WKN";s:6:"A3DMC3";s:16:"ShortDescription";s:25:"TME PHARM.CONF.IPO EO 1,-";s:13:"AbsoluteValue";d:27080;s:13:"RelativeValue";d:-192.86656944672458;s:12:"AbsoluteGain";N;s:12:"RelativeGain";N;s:8:"Quantity";d:400000;}i:14;a:8:{s:4:"ISIN";s:12:"US01609W1027";s:3:"WKN";s:6:"A117ME";s:16:"ShortDescription";s:24:"ALIBABA GR.HLDG SP.ADR 8";s:13:"AbsoluteValue";d:15394.5;s:13:"RelativeValue";d:-109.64122612066475;s:12:"AbsoluteGain";d:3177.99999999999;s:12:"RelativeGain";d:0.26013997462448224;s:8:"Quantity";d:165;}i:15;a:8:{s:4:"ISIN";s:12:"FR0013333077";s:3:"WKN";s:6:"A3CRZT";s:16:"ShortDescription";s:25:"CARVOLIX S.A. EO 1";s:13:"AbsoluteValue";d:35500;s:13:"RelativeValue";d:-252.8346829896131;s:12:"AbsoluteGain";d:21260;s:12:"RelativeGain";d:1.4929775280898876;s:8:"Quantity";d:10000;}i:16;a:8:{s:4:"ISIN";s:12:"FR0011271600";s:3:"WKN";s:6:"A1103M";s:16:"ShortDescription";s:25:"FERMENTALG EO -,04";s:13:"AbsoluteValue";d:30810;s:13:"RelativeValue";d:-219.43201641999943;s:12:"AbsoluteGain";d:-30339.999999985;s:12:"RelativeGain";d:-0.4961569910056;s:8:"Quantity";d:65000;}i:17;a:8:{s:4:"ISIN";s:12:"KYG608371046";s:3:"WKN";s:6:"A1C5AB";s:16:"ShortDescription";s:25:"MICRP.SCIEN.REGS HD-00001";s:13:"AbsoluteValue";d:2449.5;s:13:"RelativeValue";d:-17.445593126283303;s:12:"AbsoluteGain";d:-1217.999999997;s:12:"RelativeGain";d:-0.3321063394677563;s:8:"Quantity";d:3450;}i:18;a:8:{s:4:"ISIN";s:12:"KYG6683N1034";s:3:"WKN";s:6:"A3C82G";s:16:"ShortDescription";s:25:"NU HLDGS CL.A DL-,000066";s:13:"AbsoluteValue";d:11180;s:13:"RelativeValue";d:-79.62511988236265;s:12:"AbsoluteGain";d:-516;s:12:"RelativeGain";d:-0.04411764705882353;s:8:"Quantity";d:1000;}i:19;a:8:{s:4:"ISIN";s:12:"DE000A4BGGM7";s:3:"WKN";s:6:"A4BGGM";s:16:"ShortDescription";s:25:"BIOFRONTERA AG NA ON KONV";s:13:"AbsoluteValue";d:11815.5756;s:13:"RelativeValue";d:-84.15175524410725;s:12:"AbsoluteGain";d:-64563.42439999224;s:12:"RelativeGain";d:-0.845303347778824;s:8:"Quantity";d:5182.27;}i:20;a:8:{s:4:"ISIN";s:12:"DE000EWG0LD1";s:3:"WKN";s:6:"EWG0LD";s:16:"ShortDescription";s:10:"EUWAX GOLD";s:13:"AbsoluteValue";d:118941;s:13:"RelativeValue";d:-847.1101416751428;s:12:"AbsoluteGain";d:67931;s:12:"RelativeGain";d:1.331719270731229;s:8:"Quantity";d:1000;}i:21;a:8:{s:4:"ISIN";s:12:"DE000A3H2101";s:3:"WKN";s:6:"A3H210";s:16:"ShortDescription";s:23:"AAP IMPLANTATE AG KONV.";s:13:"AbsoluteValue";d:26850;s:13:"RelativeValue";d:-191.22848558510174;s:12:"AbsoluteGain";d:-12040.000000005;s:12:"RelativeGain";d:-0.30959115453853053;s:8:"Quantity";d:15000;}i:22;a:8:{s:4:"ISIN";s:12:"AU000000TLG7";s:3:"WKN";s:6:"A1C0Q2";s:16:"ShortDescription";s:20:"TALGA RESOURCES LTD.";s:13:"AbsoluteValue";d:4380;s:13:"RelativeValue";d:-31.194814408295926;s:12:"AbsoluteGain";d:-4020;s:12:"RelativeGain";d:-0.4785714285714286;s:8:"Quantity";d:30000;}i:23;a:8:{s:4:"ISIN";s:12:"AU000000DRO2";s:3:"WKN";s:6:"A2DMAA";s:16:"ShortDescription";s:15:"DRONESHIELD LTD";s:13:"AbsoluteValue";d:70600.2;s:13:"RelativeValue";d:-502.8219489015009;s:12:"AbsoluteGain";d:52717.6000000078;s:12:"RelativeGain";d:2.9479829555003634;s:8:"Quantity";d:41800;}i:24;a:8:{s:4:"ISIN";s:12:"CA0585861085";s:3:"WKN";s:6:"A0RENB";s:16:"ShortDescription";s:15:"BALLARD PWR SYS";s:13:"AbsoluteValue";d:28816;s:13:"RelativeValue";d:-205.23054155010396;s:12:"AbsoluteGain";d:-32497.5;s:12:"RelativeGain";d:-0.5300219364414036;s:8:"Quantity";d:8000;}i:25;a:8:{s:4:"ISIN";s:12:"CA73044W3021";s:3:"WKN";s:6:"A3DWD8";s:16:"ShortDescription";s:15:"POET TECHS INC.";s:13:"AbsoluteValue";d:154875;s:13:"RelativeValue";d:-1103.0358176906009;s:12:"AbsoluteGain";d:100195.76666666174;s:12:"RelativeGain";d:1.8324281552347919;s:8:"Quantity";d:14750;}i:26;a:8:{s:4:"ISIN";s:12:"CA81752F1062";s:3:"WKN";s:6:"A411DW";s:16:"ShortDescription";s:23:"SERNOVA BIOTHERAPEUTICS";s:13:"AbsoluteValue";d:14700;s:13:"RelativeValue";d:-104.69492506893837;s:12:"AbsoluteGain";d:-32064.3999999;s:12:"RelativeGain";d:-0.6856583212864608;s:8:"Quantity";d:150000;}i:27;a:8:{s:4:"ISIN";s:12:"CA67059R1091";s:3:"WKN";s:6:"A3DNSU";s:16:"ShortDescription";s:22:"NUREXONE BIOLOGIC INC.";s:13:"AbsoluteValue";d:16700;s:13:"RelativeValue";d:-118.93913256131094;s:12:"AbsoluteGain";d:7240;s:12:"RelativeGain";d:0.7653276955602537;s:8:"Quantity";d:50000;}i:28;a:8:{s:4:"ISIN";s:12:"CA24463V1013";s:3:"WKN";s:6:"A3CN14";s:16:"ShortDescription";s:25:"DEFENCE THERAPEUTICS A";s:13:"AbsoluteValue";d:4175.6;s:13:"RelativeValue";d:-29.73905640257545;s:12:"AbsoluteGain";d:-13166.8999999966;s:12:"RelativeGain";d:-0.7592273316995347;s:8:"Quantity";d:14300;}i:29;a:8:{s:4:"ISIN";s:12:"DE0005203947";s:3:"WKN";s:6:"520394";s:16:"ShortDescription";s:21:"BRAIN BIOTEC NA O.N.";s:13:"AbsoluteValue";d:19040;s:13:"RelativeValue";d:-135.60485532738684;s:12:"AbsoluteGain";d:-24719.9999999996;s:12:"RelativeGain";d:-0.5648994515539265;s:8:"Quantity";d:6800;}i:30;a:8:{s:4:"ISIN";s:12:"CNE100000296";s:3:"WKN";s:6:"A0M4W9";s:16:"ShortDescription";s:3:"BYD";s:13:"AbsoluteValue";d:18102;s:13:"RelativeValue";d:-128.92432201346412;s:12:"AbsoluteGain";d:-35058;s:12:"RelativeGain";d:-0.6594808126410835;s:8:"Quantity";d:2000;}i:31;a:8:{s:4:"ISIN";s:12:"CH0454664001";s:3:"WKN";s:6:"A2T64E";s:16:"ShortDescription";s:23:"21SHARES BITCOIN ETP OE";s:13:"AbsoluteValue";d:117209.6;s:13:"RelativeValue";d:-834.778931248996;s:12:"AbsoluteGain";d:53712.4571428544;s:12:"RelativeGain";d:0.8459035277177028;s:8:"Quantity";d:6400;}i:32;a:8:{s:4:"ISIN";s:12:"CH0454664027";s:3:"WKN";s:6:"A2T68Z";s:16:"ShortDescription";s:21:"21SHARES ETHER ETP OE";s:13:"AbsoluteValue";d:104189.4;s:13:"RelativeValue";d:-742.0477160529013;s:12:"AbsoluteGain";d:20962.8242840205;s:12:"RelativeGain";d:0.2518765683158539;s:8:"Quantity";d:6300;}i:33;a:8:{s:4:"ISIN";s:12:"CH1114873776";s:3:"WKN";s:6:"A3GSS0";s:16:"ShortDescription";s:22:"21SHARES SOLANA ETP OE";s:13:"AbsoluteValue";d:10198.5;s:13:"RelativeValue";d:-72.63477505548082;s:12:"AbsoluteGain";d:-6939;s:12:"RelativeGain";d:-0.4049015317286652;s:8:"Quantity";d:250;}i:34;a:8:{s:4:"ISIN";s:12:"DE000A37FT41";s:3:"WKN";s:6:"A37FT4";s:16:"ShortDescription";s:22:"EPIGENOMICS AG NA O.N.";s:13:"AbsoluteValue";d:2436;s:13:"RelativeValue";d:-17.349444725709787;s:12:"AbsoluteGain";N;s:12:"RelativeGain";N;s:8:"Quantity";d:2800;}i:35;a:8:{s:4:"ISIN";s:12:"DE000A3E5A34";s:3:"WKN";s:6:"A3E5A3";s:16:"ShortDescription";s:17:"PARTEC AG NA O.N.";s:13:"AbsoluteValue";d:13550;s:13:"RelativeValue";d:-96.50450576082416;s:12:"AbsoluteGain";d:-8976.999999999;s:12:"RelativeGain";d:-0.3984995782838105;s:8:"Quantity";d:1000;}i:36;a:8:{s:4:"ISIN";s:12:"DE000A40AEG0";s:3:"WKN";s:6:"A40AEG";s:16:"ShortDescription";s:25:"PENTIXAPHARM HLDG NA O.N.";s:13:"AbsoluteValue";d:15540;s:13:"RelativeValue";d:-110.67749221573486;s:12:"AbsoluteGain";d:-4174.000000002;s:12:"RelativeGain";d:-0.21172770619872053;s:8:"Quantity";d:7000;}i:37;a:8:{s:4:"ISIN";s:12:"DE000A255G02";s:3:"WKN";s:6:"A255G0";s:16:"ShortDescription";s:20:"ENAPTER AG INH O.N.";s:13:"AbsoluteValue";d:5380;s:13:"RelativeValue";d:-38.31691815448221;s:12:"AbsoluteGain";d:-1215;s:12:"RelativeGain";d:-0.18423047763457165;s:8:"Quantity";d:4000;}i:38;a:8:{s:4:"ISIN";s:12:"DE000A0Z2ZZ5";s:3:"WKN";s:6:"A0Z2ZZ";s:16:"ShortDescription";s:18:"FREENET AG NA O.N.";s:13:"AbsoluteValue";d:251.4;s:13:"RelativeValue";d:-1.790496881791232;s:12:"AbsoluteGain";d:-15;s:12:"RelativeGain";d:-0.05630630630630631;s:8:"Quantity";d:10;}i:39;a:8:{s:4:"ISIN";s:12:"DE000A1EWVY8";s:3:"WKN";s:6:"A1EWVY";s:16:"ShortDescription";s:11:"FORMYCON AG";s:13:"AbsoluteValue";d:29850;s:13:"RelativeValue";d:-212.59479682366057;s:12:"AbsoluteGain";d:-41644.9999999995;s:12:"RelativeGain";d:-0.5824882858941155;s:8:"Quantity";d:1500;}i:40;a:8:{s:4:"ISIN";s:12:"DE000A0XYG76";s:3:"WKN";s:6:"A0XYG7";s:16:"ShortDescription";s:22:"DT.ROHSTOFF AG NA O.N.";s:13:"AbsoluteValue";d:30555;s:13:"RelativeValue";d:-217.61587996472193;s:12:"AbsoluteGain";d:21280;s:12:"RelativeGain";d:2.2943396226415094;s:8:"Quantity";d:350;}i:41;a:8:{s:4:"ISIN";s:12:"DE0005659700";s:3:"WKN";s:6:"565970";s:16:"ShortDescription";s:24:"ECKERT+ZIEGLER INH O.N.";s:13:"AbsoluteValue";d:6959.8;s:13:"RelativeValue";d:-49.5684176527073;s:12:"AbsoluteGain";d:-1157.19999999998;s:12:"RelativeGain";d:-0.14256498706418416;s:8:"Quantity";d:460;}i:42;a:8:{s:4:"ISIN";s:12:"DE0005664809";s:3:"WKN";s:6:"566480";s:16:"ShortDescription";s:19:"EVOTEC SE INH O.N.";s:13:"AbsoluteValue";d:8136.24;s:13:"RelativeValue";d:-57.94714538387069;s:12:"AbsoluteGain";d:-43113.35999999952;s:12:"RelativeGain";d:-0.8412428584808452;s:8:"Quantity";d:1740;}i:43;a:8:{s:4:"ISIN";s:12:"DE0005932735";s:3:"WKN";s:6:"593273";s:16:"ShortDescription";s:11:"YOC AG O.N.";s:13:"AbsoluteValue";d:5024;s:13:"RelativeValue";d:-35.781449220839896;s:12:"AbsoluteGain";d:526.6000000008;s:12:"RelativeGain";d:0.11708987414970731;s:8:"Quantity";d:800;}}" ] "licence_switzerland" => array:1 [ "x-default" => "0" ] "perf1m" => array:1 [ "x-default" => "-9.31723" ] "perf12m" => array:1 [ "x-default" => "-1.61177" ] "perfever" => array:1 [ "x-default" => "-2.64797" ] "aum" => array:1 [ "x-default" => "10217.3" ] "topwikis" => array:1 [ "x-default" => "2094" ] "created" => array:1 [ "x-default" => "1649766873" ] "changed" => array:1 [ "x-default" => "1781731508" ] "solid_valor" => array:1 [ "x-default" => "112327161" ] "solid_bc" => array:1 [ "x-default" => "LSD" ] "solid_bc_id" => array:1 [ "x-default" => "2913" ] "solid_cc" => array:1 [ "x-default" => "EUR" ] "solid_cc_id" => array:1 [ "x-default" => "814" ] "fullquote_link" => array:1 [ "x-default" => "wikifolio/wfcli-lgsz-open-112327161/lsd/eur" ] "solid_changed" => array:1 [ "x-default" => "1661264169" ] ] #fields: [] #fieldDefinitions: null #languages: array:4 [ "en" => Drupal\Core\Language\Language {#1729 #name: "Englisch" #id: "en" #direction: "ltr" #weight: 0 #locked: false } "de" => Drupal\Core\Language\Language {#1728 #name: "Deutsch" #id: "de" #direction: "ltr" #weight: 1 #locked: false } "und" => Drupal\Core\Language\Language {#1730 #name: "Nicht angegeben" #id: "und" #direction: "ltr" #weight: 2 #locked: true } "zxx" => Drupal\Core\Language\Language {#1722 #name: "Nicht zutreffend" #id: "zxx" #direction: "ltr" #weight: 3 #locked: true } ] #langcodeKey: "" #defaultLangcodeKey: "default_langcode" #activeLangcode: "x-default" #enforceDefaultTranslation: null #defaultLangcode: "und" #translations: array:1 [ "x-default" => array:1 [ "status" => 1 ] ] #translationInitialize: false #newRevision: false #isDefaultRevision: true #entityKeys: array:3 [ "bundle" => "wikifolio" "id" => "8543" "label" => "8543" ] #translatableEntityKeys: [] #validated: false #validationRequired: false #loadedRevisionId: null #revisionTranslationAffectedKey: "revision_translation_affected" #enforceRevisionTranslationAffected: [] #isSyncing: false } "_route" => "entity.wikifolio.devel_render" "_route_object" => Symfony\Component\Routing\Route {#1583 -path: "/devel/render/wikifolio/{wikifolio}" -host: "" -schemes: [] -methods: [] -defaults: array:2 [ "_controller" => "Drupal\devel\Controller\EntityDebugController::entityRender" "_title" => "Devel Render" ] -requirements: array:1 [ "_permission" => "access devel information" ] -options: array:6 [ "compiler_class" => "Drupal\Core\Routing\RouteCompiler" "_admin_route" => true "_devel_entity_type_id" => "wikifolio" "parameters" => array:1 [ "wikifolio" => array:2 [ "type" => "entity:wikifolio" "converter" => "paramconverter.entity" ] ] "_access_checks" => array:1 [ 0 => "access_check.permission" ] "utf8" => true ] -condition: "" -compiled: Drupal\Core\Routing\CompiledRoute {#1579 -variables: array:1 [ 0 => "wikifolio" ] -tokens: array:2 [ 0 => array:5 [ 0 => "variable" 1 => "/" 2 => "[^/]++" 3 => "wikifolio" 4 => true ] 1 => array:2 [ 0 => "text" 1 => "/devel/render/wikifolio" ] ] -staticPrefix: "" -regex: "{^/devel/render/wikifolio/(?P<wikifolio>[^/]++)$}sDu" -pathVariables: array:1 [ 0 => "wikifolio" ] -hostVariables: [] -hostRegex: null -hostTokens: [] #fit: 14 #patternOutline: "/devel/render/wikifolio/%" #numParts: 4 } } "_raw_variables" => Symfony\Component\HttpFoundation\InputBag {#1585 #parameters: array:1 [ "wikifolio" => "8543" ] } ]